The active ingredient in Arixtra, fondaparinux sodium, stops one of the substances (factors) that are involved in the clotting of blood, Factor Xa.
Det aktive stof i Arixtra, fondaparinuxnatrium, blokerer et af de stoffer, faktor Xa, der medvirker ved blodets størkning.